Denali Therapeutics Inc (DNLI) Dividend History
Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
Last update 12/11/2023
Dividend Yield Summary
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
| Dividends | - | - | - | - | - | - |
| Average Price | 19.71 | 33.88 | 58.02 | 30.73 | 25.73 | - |
| Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
| Date | Amount Per Share | Note |